Research and exclusive LICENSE AGREEMENTResearch and Exclusive License Agreement • May 14th, 2018 • Arcturus Therapeutics Ltd. • Pharmaceutical preparations • California
This Research and Exclusive License Agreement (“Agreement”) is entered into by and between Arcturus Therapeutics, Inc., a Delaware corporation (“Arcturus”), and Synthetic Genomics, Inc., a Delaware corporation (“SGI”) and effective October 24, 2017 (“Effective Date”). SGI and Arcturus may each be referred to herein individually as a “Party” and collectively as the “Parties.” In consideration of the mutual covenants and promises set forth in this Agreement, the Parties agree as follows:
